Announced
Completed
Synopsis
Sorrento, a clinical and commercial stage biopharmaceutical company, completed the acquisition of Virex Health, a biotechnology firm that enables widespread testing in life. Financial terms were not disclosed. “We at Sorrento are amazed by the unmatched sensitivity of the Virex tests for detecting the virus that causes Covid-19 and are excited to mass produce and commercialize the rapid at-home tests for daily Covid-19 testing and frequent early cancer detection,” Henry Ji, Sorrento Chairman and CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.